Clinical Trial

Xenon MRI Pulm Hypertension

Study acronym: Jupiter PH
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The overall objective outlined in this study is to determine how pulmonary vascular remodeling in PAH at a cellular and pathological level is associated with changes in gas exchange physiology and hemodynamics (monitored with 129Xe MRI/MRS) and how these signals change with disease progression or treatment.
Protocol Amendment History 1 change
critical Trial status changed: Terminated → Recruiting 2026-08-11
Trial Details
NCT Number NCT04991454
Lead Sponsor Bastiaan Driehuys
Conditions Pulmonary Hypertension, Pulmonary Arterial Hypertension
Enrollment 20 participants
Start Date 2021-09-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10